The legal media outlet GRCD recently announced their 2026 Top 15 Preferred Lawyers in China in three major fields. Thanks to their solid professional skills and extensive experience, JunHe’s LI, Deting, WU, Yu (Sophia) and YUAN, Yifeng (Vincent) were included on the lists for new energy, intellectual property and banking and finance, respectively.

• GRCD Top 15 Preferred New Energy Lawyers in China – LI, Deting

• GRCD Top 15 Preferred Intellectual Property Lawyers in China – WU, Yu (Sophia)

• GRCD Top 15 Preferred Banking and Finance Lawyers in China – YUAN, Yifeng (Vincent)

Mr. LI, Deting has been working in the new energy and infrastructure sector for over 20 years, witnessing the industry's growth from inception to rapid expansion and structural adjustment. He has a solid understanding of policy evolution and industry trends. Mr. Li’s work covers greenfield investments, mergers and acquisitions and financing for domestic and international new energy projects and he has served a wide range of market entities including developers, equipment suppliers, contractors and financing institutions. With his industry acumen developed from years of frontline experience, he helps clients identify risks and find feasible paths in complex geopolitical and regulatory environments, balancing transaction structures and compliance frameworks. From acquiring large domestic new energy power station asset packages to developing greenfield projects and acquiring brownfield projects abroad, Mr. Li has built a representative project portfolio in the new energy sector. He has been repeatedly listed as a recommended lawyer in Projects and Energy by The Legal 500 and as a Rising Star Partner in Energy and Infrastructure by IFLR1000. Beyond his practice, Mr. Li focuses on new energy law, writing professional articles on energy storage, green certificates, green electricity trading, carbon emission rights pledges, hydrogen energy, the EU Carbon Border Adjustment Mechanism (CBAM) and battery passports.

The legal battles in the new energy sector involve precise control over policy context and asset structures, while the biopharmaceutical sector, which also relies heavily on technological innovation, tests the meticulous and forward-looking planning of IP lawyers. Ms. [[WU, Yu (Sophia)]], a leading lawyer in JunHe’s patent group, combines a background in science and engineering with legal depth to provide comprehensive IP strategies for innovative pharmaceutical companies. Her representative achievements span three major areas. In the areas of cross-border technology transactions, in 2024 she assisted Chengdu Enmu in selling the global rights to a tri-specific TCE antibody innovative drug to GSK, covering patent layout, IP due diligence and cross-border IP asset delivery. In the area of capital markets, Ms. Wu has provided IP due diligence for a series of biopharmaceutical companies including Viela Bio for their Hong Kong stock listings. This covered popular tracks such as bispecific antibodies, ADCs and GLP-1s. In the areas of frontier technology investments, she has represented institutions like Qiming Venture Partners and AstraZeneca CICC in conducting patent due diligence and FTO analysis on cutting-edge technologies including gene editing, base editing, ADCs and small molecules. Ms. Wu has been recognized repeatedly as a Rising Star Lawyer in the Intellectual Property category by The Legal 500 Asia Pacific and she was awarded Lawyer of the Year Rising Star by China Business Law Journal. She maintains a passion for exploring frontier issues in pharmaceutical IP and has produced professional research papers and participated in industry exchange platforms. She has also delivered keynote speeches at intellectual property and pharmaceutical forums to share her insights with her peers.

From intellectual property in the biopharmaceutical field to the financing structures behind capital market transactions, JunHe’s professional landscape has professionals in various fields. Mr.[[YUAN, Yifeng (Vincent)]] has worked in the banking and finance sector for 14 years and is a prominent lawyer in domestic M&A financing. In the area of privatization delistings, he has completed several M&A financing transactions as the lead partner. This includes the privatization of Jinke Services by Boyu Capital which spanned both H-share and US stock markets. In control acquisition and equity restructuring, he represented PAG in completing the acquisition financing for the control of Stellar Cinemas. In the sale of Yingde Gases equity by PAG,  Mr. Yuan coordinated multiple financing arrangements including offshore bridge loans, domestic restructuring and M&A loans. These transactions cover industries such as industrial gases and data centers, with partner institutions spanning multiple leading financial and investment entities. Whether representing lenders to coordinate syndicates or designing financing structures on the acquirer’s side, Mr. Yuan accurately balances complex commercial demands and legal constraints. Since 2017, he has been recognized as a recommended lawyer by The Legal 500 for ten consecutive years and from 2023 to 2025 he was included in the IFLR1000 annual list as a Rising Star Partner.